Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle R Lofwall

Showing results (61-70 of 126) with videos related to

Pageof 13
Sort By:
JAMA|July 20, 2016
Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical TrialRichard N Rosenthal, Michelle R Lofwall, Sonnie Kim, et al.
Journal of Clinical Psychopharmacology|June 15, 2016
A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical TrialsAidan J Hampson, Shanna Babalonis, Michelle R Lofwall, et al.
Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care|December 27, 2023
Get It in Writing: How to Make Medications for Opioid Use Disorder Available During IncarcerationMargaret McGladrey, Jordan Kelsch, Michelle R Lofwall, et al.
Health Services Research|February 8, 2020
Association between state Medicaid expansion status and naloxone prescription dispensingMinji Sohn, Jeffery C Talbert, Chris Delcher, et al.
Journal of Addiction Medicine|March 24, 2025
Civil Rights Laws for People With Opioid Use Disorder in the Emergency DepartmentAnna-Maria South, Kathryn Hawk, Sally Friedman, et al.
Drug and Alcohol Dependence|November 17, 2019
Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting systemRachel Vickers-Smith, Jiangwen Sun, Richard J Charnigo, et al.
Substance Abuse Treatment, Prevention, and Policy|April 2, 2025
Barriers and facilitators to scaling up medications for opioid use disorder in Kentucky: qualitative perspectives of treatment organization staffHannah K Knudsen, Shaquita Andrews-Higgins, Sandra Back-Haddix, et al.
Substance Abuse Treatment, Prevention, and Policy|August 18, 2017
A mixed methods study of HIV-related services in buprenorphine treatmentHannah K Knudsen, Jennifer Cook, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|October 21, 2015
Safety of oral dronabinol during opioid withdrawal in humansCrystal J Jicha, Michelle R Lofwall, Paul A Nuzzo, et al.
Research Square|December 23, 2024
Scaling up medications for opioid use disorder in Kentucky: Qualitative perspectives of treatment organizationsHannah K Knudsen, Shaquita Andrews-Higgins, Sandra Back-Haddix, et al.
Pageof 13

Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
JAMA|July 20, 2016
Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical TrialRichard N Rosenthal, Michelle R Lofwall, Sonnie Kim, et al.
Journal of Clinical Psychopharmacology|June 15, 2016
A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical TrialsAidan J Hampson, Shanna Babalonis, Michelle R Lofwall, et al.
Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care|December 27, 2023
Get It in Writing: How to Make Medications for Opioid Use Disorder Available During IncarcerationMargaret McGladrey, Jordan Kelsch, Michelle R Lofwall, et al.
Health Services Research|February 8, 2020
Association between state Medicaid expansion status and naloxone prescription dispensingMinji Sohn, Jeffery C Talbert, Chris Delcher, et al.
Journal of Addiction Medicine|March 24, 2025
Civil Rights Laws for People With Opioid Use Disorder in the Emergency DepartmentAnna-Maria South, Kathryn Hawk, Sally Friedman, et al.
Drug and Alcohol Dependence|November 17, 2019
Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting systemRachel Vickers-Smith, Jiangwen Sun, Richard J Charnigo, et al.
Substance Abuse Treatment, Prevention, and Policy|April 2, 2025
Barriers and facilitators to scaling up medications for opioid use disorder in Kentucky: qualitative perspectives of treatment organization staffHannah K Knudsen, Shaquita Andrews-Higgins, Sandra Back-Haddix, et al.
Substance Abuse Treatment, Prevention, and Policy|August 18, 2017
A mixed methods study of HIV-related services in buprenorphine treatmentHannah K Knudsen, Jennifer Cook, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|October 21, 2015
Safety of oral dronabinol during opioid withdrawal in humansCrystal J Jicha, Michelle R Lofwall, Paul A Nuzzo, et al.
Research Square|December 23, 2024
Scaling up medications for opioid use disorder in Kentucky: Qualitative perspectives of treatment organizationsHannah K Knudsen, Shaquita Andrews-Higgins, Sandra Back-Haddix, et al.
Pageof 13